- Home
- AUTL vs NRDS Comparison
AUTL vs NRDS Comparison
Compare AUTL & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | NRDS |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 631.6M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AUTL | NRDS |
|---|---|---|
| Price | $1.89 | $8.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.5M | 636.8K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.42 |
| EPS | N/A | ★ 0.37 |
| Revenue | $10,120,000.00 | ★ $836,600,000.00 |
| Revenue This Year | $80.32 | $10.13 |
| Revenue Next Year | $53.96 | $7.11 |
| P/E Ratio | ★ N/A | $22.16 |
| Revenue Growth | ★ 496.00 | 21.67 |
| 52 Week Low | $1.18 | $7.33 |
| 52 Week High | $2.58 | $16.24 |
Technical Indicators
Market Signals| Indicator | AUTL | NRDS |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 34.35 |
| Support Level | $1.84 | $8.19 |
| Resistance Level | $1.92 | $8.81 |
| Average True Range (ATR) | 0.09 | 0.30 |
| MACD | -0.02 | -0.15 |
| Stochastic Oscillator | 8.89 | 23.28 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.